The rapid production of safe, effective and consistent vaccines is essential for supporting COVID-19 immunisation programmes in the UK and globally. However, manufacturing vaccines is challenging for various reasons that include the complex processes involved, the specialist knowledge and experience required, and the natural variability of the biological materials and systems used. Urgent demand is leading to manufacturers and governments taking on significant financial risks in order to speed up production. What is the UK Government doing to accelerate vaccine manufacture? How are vaccines made? Why is manufacturing vaccines at large scales so challenging?
Documents to download
-
Wildlife diseases, April 2008 (119 KB, PDF)
Documents to download
-
Wildlife diseases, April 2008 (119 KB, PDF)
Related posts
-
-
Large-scale woodland creation is being promoted internationally to mitigate climate change. It can also supply other benefits, such as improving biodiversity, air and water quality. This POSTnote summarises key factors influencing how much carbon is taken up by woodland, the different objectives of woodland creation, constraints to increasing UK tree cover and different finance options.
-
The digital divide is the gap between people in society who have full access to digital technologies (such as the internet and computers) and those who do not. Concerns about the digital divide have been particularly acute during the COVID-19 pandemic as the internet and digital devices have played an important role in allowing people to access services, attend medical appointments and stay in touch with friends and family. What impact has the digital divide had on children and adults in the UK during the COVID-19 pandemic and what has been done to tackle it?
